AMPE
Ampio Pharmaceuticals, Inc.
Price Chart
Latest Quote
$0.26
Current Price| Previous Close | $0.26 |
| Open | $0.01 |
| Day High | $0.01 |
| Day Low | $0.01 |
| Volume | 334 |
Stock Information
| Shares Outstanding | 1.14M |
| Total Debt | $451K |
| Cash Equivalents | $4.12M |
| Net Income | $-8.63M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $293K |
| EPS (TTM) | $-10.66 |
| Exchange | PNK |
đ Custom Metrics & Score
Score: 14/42| Debt to Equity | 0.08 |
| Debt to Earnings | -0.03 |
| Current Ratio | 2.41 |
| Quick Ratio | 2.11 |
| Return on Equity | -256.90% |
| Avg FCF Growth | -13.21% |
| FCF Yield | -2923.08% |
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-02-02 | $0.01 | 176 |
| 2026-01-30 | $0.26 | 1,359 |
| 2026-01-29 | $0.26 | 0 |
| 2026-01-28 | $0.26 | 0 |
| 2026-01-27 | $0.26 | 1,850 |
| 2026-01-26 | $0.26 | 0 |
| 2026-01-23 | $0.26 | 1,063 |
| 2026-01-22 | $0.26 | 0 |
| 2026-01-21 | $0.26 | 0 |
| 2026-01-20 | $0.26 | 245 |
| 2026-01-16 | $0.26 | 0 |
| 2026-01-15 | $0.26 | 1,262 |
| 2026-01-14 | $0.25 | 1,486 |
| 2026-01-13 | $0.25 | 0 |
| 2026-01-12 | $0.25 | 185 |
| 2026-01-09 | $0.25 | 0 |
| 2026-01-08 | $0.25 | 49,003 |
| 2026-01-07 | $0.01 | 0 |
| 2026-01-06 | $0.01 | 214 |
| 2026-01-05 | $0.01 | 157 |
About Ampio Pharmaceuticals, Inc.
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. The company develops OA-201, a small molecule formulation for the treatment of OAK pain. Ampio Pharmaceuticals, Inc. is based in Englewood, Colorado.
đ° Latest News
No news articles available at the moment. Check back later for updates on AMPE.
Income Statement (Annual)
Revenue
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Total Revenue | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 |
Expenses
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Total Expenses | $9,518,000 | $20,382,000 | $20,571,000 |
| Other Income Expense | $538,000 | $3,825,000 | $3,492,000 |
| Other Non Operating Income Expenses | $594,000 | - | - |
| Net Non Operating Interest Income Expense | $348,000 | $220,000 | $4,000 |
| Operating Expense | $9,518,000 | $20,382,000 | $20,571,000 |
| General And Administrative Expense | $7,079,000 | $11,466,000 | $8,671,000 |
Income & Earnings
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Net Income From Continuing Operation Net Minority Interest | $-8,632,000 | $-16,337,000 | $-17,075,000 |
| Net Interest Income | $348,000 | $220,000 | $4,000 |
| Interest Income | $348,000 | $220,000 | $4,000 |
| Normalized Income | $-8,576,000 | $-20,162,000 | $-20,567,000 |
| Net Income From Continuing And Discontinued Operation | $-8,632,000 | $-16,337,000 | $-17,075,000 |
| Average Dilution Earnings | $0 | $-5,761,000 | - |
| Net Income Common Stockholders | $-8,632,000 | $-16,337,000 | $-17,075,000 |
| Net Income | $-8,632,000 | $-16,337,000 | $-17,075,000 |
| Net Income Including Noncontrolling Interests | $-8,632,000 | $-16,337,000 | $-17,075,000 |
| Net Income Continuous Operations | $-8,632,000 | $-16,337,000 | $-17,075,000 |
| Pretax Income | $-8,632,000 | $-16,337,000 | $-17,075,000 |
| Special Income Charges | $-56,000 | $-1,936,000 | $0 |
| Interest Income Non Operating | $348,000 | $220,000 | $4,000 |
| Operating Income | $-9,518,000 | $-20,382,000 | $-20,571,000 |
| Depreciation Amortization Depletion Income Statement | - | - | $24,000 |
| Depreciation And Amortization In Income Statement | - | - | $24,000 |
| Depreciation Income Statement | - | - | $24,000 |
Per Share Metrics
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Diluted EPS | - | $-29.32 | $-30.00 |
| Basic EPS | - | $-21.68 | $-27.00 |
Other
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Tax Effect Of Unusual Items | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-9,340,000 | $-23,159,000 | $-22,969,000 |
| Total Unusual Items | $-56,000 | $3,825,000 | $3,492,000 |
| Total Unusual Items Excluding Goodwill | $-56,000 | $3,825,000 | $3,492,000 |
| Reconciled Depreciation | $122,000 | $1,048,000 | $1,094,000 |
| EBITDA (Bullshit earnings) | $-9,396,000 | $-19,334,000 | $-19,477,000 |
| EBIT | $-9,518,000 | $-20,382,000 | $-20,571,000 |
| Diluted NI Availto Com Stockholders | $-8,632,000 | $-22,098,000 | $-17,075,000 |
| Gain On Sale Of Ppe | $-56,000 | $0 | $0 |
| Impairment Of Capital Assets | $0 | $1,936,000 | $0 |
| Research And Development | $2,439,000 | $8,916,000 | $11,900,000 |
| Selling General And Administration | $7,079,000 | $11,466,000 | $8,671,000 |
| Other Gand A | $4,591,000 | $7,731,000 | $3,236,000 |
| Insurance And Claims | $964,000 | $1,124,000 | $1,186,000 |
| Salaries And Wages | $1,524,000 | $2,611,000 | $4,249,000 |
| Diluted Average Shares | - | $753,615 | $683,210 |
| Basic Average Shares | - | $753,615 | $664,330 |
| Gain On Sale Of Security | - | $5,761,000 | $3,492,000 |
Balance Sheet (Annual)
Assets
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Net Tangible Assets | $3,360,000 | $11,789,000 | $27,284,000 |
| Total Assets | $5,736,000 | $13,588,000 | $38,825,000 |
| Total Non Current Assets | $0 | $259,000 | $3,193,000 |
| Current Assets | $5,736,000 | $13,329,000 | $35,632,000 |
| Other Current Assets | $342,000 | $642,000 | $549,000 |
| Current Deferred Assets | $136,000 | $0 | - |
| Prepaid Assets | $249,000 | $34,000 | $1,119,000 |
| Receivables | $920,000 | $0 | $16,000 |
| Other Receivables | $920,000 | - | $16,000 |
| Cash Cash Equivalents And Short Term Investments | $4,089,000 | $12,653,000 | $33,892,000 |
| Cash And Cash Equivalents | $4,089,000 | $12,653,000 | $33,892,000 |
| Inventory | - | $0 | $72,000 |
Debt
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Total Debt | $274,000 | $614,000 | $925,000 |
| Long Term Debt And Capital Lease Obligation | $0 | $274,000 | $614,000 |
| Current Debt And Capital Lease Obligation | $274,000 | $340,000 | $311,000 |
Liabilities
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Total Liabilities Net Minority Interest | $2,376,000 | $1,799,000 | $11,541,000 |
| Total Non Current Liabilities Net Minority Interest | $0 | $607,000 | $6,419,000 |
| Derivative Product Liabilities | $0 | $44,000 | $5,805,000 |
| Current Liabilities | $2,376,000 | $1,192,000 | $5,122,000 |
| Payables And Accrued Expenses | $2,102,000 | $709,000 | $4,422,000 |
| Payables | $834,000 | $249,000 | $427,000 |
| Other Payable | $62,000 | - | - |
| Total Tax Payable | $22,000 | $152,000 | - |
| Accounts Payable | $750,000 | $97,000 | $427,000 |
Equity
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Common Stock Equity | $3,360,000 | $11,789,000 | $27,284,000 |
| Total Equity Gross Minority Interest | $3,360,000 | $11,789,000 | $27,284,000 |
| Stockholders Equity | $3,360,000 | $11,789,000 | $27,284,000 |
| Retained Earnings | $-242,527,000 | $-233,939,000 | $-217,602,000 |
Other
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Ordinary Shares Number | $833,430 | $755,143 | $11,366,269 |
| Share Issued | $833,430 | $755,143 | $11,366,269 |
| Tangible Book Value | $3,360,000 | $11,789,000 | $27,284,000 |
| Invested Capital | $3,360,000 | $11,789,000 | $27,284,000 |
| Working Capital | $3,360,000 | $12,137,000 | $30,510,000 |
| Capital Lease Obligations | $274,000 | $614,000 | $925,000 |
| Total Capitalization | $3,360,000 | $11,789,000 | $27,284,000 |
| Additional Paid In Capital | $245,887,000 | $245,728,000 | $244,884,000 |
| Capital Stock | $0 | $0 | $2,000 |
| Common Stock | $0 | $0 | $2,000 |
| Preferred Stock | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $0 | $274,000 | $614,000 |
| Current Capital Lease Obligation | $274,000 | $340,000 | $311,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $0 | $143,000 | $389,000 |
| Current Accrued Expenses | $1,268,000 | $460,000 | $3,995,000 |
| Net PPE | $0 | $259,000 | $3,193,000 |
| Accumulated Depreciation | $0 | $-9,245,000 | $-8,234,000 |
| Gross PPE | $0 | $9,504,000 | $11,427,000 |
| Leases | $0 | $4,965,000 | $6,075,000 |
| Machinery Furniture Equipment | $0 | $4,539,000 | $5,352,000 |
| Properties | $0 | $0 | $0 |
| Long Term Provisions | - | $289,000 | - |
| Other Properties | - | - | $238,000 |
| Other Inventories | - | - | $72,000 |
Cash Flow Statement (Annual)
Free Cash Flow
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Free Cash Flow | $-8,564,000 | $-21,128,000 | $-14,186,000 |
Operating Activities
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Operating Cash Flow | $-8,564,000 | $-21,128,000 | $-14,089,000 |
| Cash Flow From Continuing Operating Activities | $-8,564,000 | $-21,128,000 | $-14,089,000 |
| Operating Gains Losses | $56,000 | $-5,761,000 | $-3,492,000 |
Investing Activities
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Investing Cash Flow | $0 | $0 | $-97,000 |
| Cash Flow From Continuing Investing Activities | - | $0 | $-97,000 |
| Capital Expenditure | - | - | $-97,000 |
Financing Activities
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Issuance Of Capital Stock | $98,000 | $0 | $33,012,000 |
| Financing Cash Flow | $0 | $-111,000 | $30,732,000 |
| Cash Flow From Continuing Financing Activities | $0 | $-111,000 | $30,732,000 |
| Net Other Financing Charges | $-98,000 | $-111,000 | $-2,514,000 |
| Net Common Stock Issuance | $98,000 | $0 | $33,012,000 |
| Common Stock Issuance | $98,000 | $0 | $33,012,000 |
| Repurchase Of Capital Stock | - | - | $-186,000 |
Other
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| End Cash Position | $4,089,000 | $12,653,000 | $33,892,000 |
| Beginning Cash Position | $12,653,000 | $33,892,000 | $17,346,000 |
| Changes In Cash | $-8,564,000 | $-21,239,000 | $16,546,000 |
| Change In Working Capital | $15,000 | $-2,974,000 | $2,580,000 |
| Change In Other Current Liabilities | $-265,000 | $-79,000 | $-89,000 |
| Change In Payables And Accrued Expense | $1,251,000 | $-3,959,000 | $3,262,000 |
| Change In Prepaid Assets | $-51,000 | $1,064,000 | $-593,000 |
| Change In Receivables | $-920,000 | $0 | - |
| Other Non Cash Items | $-284,000 | $7,000 | $80,000 |
| Stock Based Compensation | $159,000 | $953,000 | $2,724,000 |
| Asset Impairment Charge | $0 | $1,936,000 | $0 |
| Depreciation Amortization Depletion | $122,000 | $1,048,000 | $1,094,000 |
| Depreciation And Amortization | $122,000 | $1,048,000 | $1,094,000 |
| Gain Loss On Sale Of PPE | $56,000 | $0 | $0 |
| Net Income From Continuing Operations | $-8,632,000 | $-16,337,000 | $-17,075,000 |
| Proceeds From Stock Option Exercised | - | $0 | $234,000 |
| Net PPE Purchase And Sale | - | $0 | $-97,000 |
| Purchase Of PPE | - | $0 | $-97,000 |
| Gain Loss On Investment Securities | - | $-5,761,000 | $-3,492,000 |
| Common Stock Payments | - | - | $-186,000 |